1. Home
  2. GEF vs TNGX Comparison

GEF vs TNGX Comparison

Compare GEF & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greif Inc.

GEF

Greif Inc.

N/A

Current Price

$87.91

Market Cap

4.9B

Sector

N/A

ML Signal

N/A

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$23.88

Market Cap

4.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GEF
TNGX
Founded
1877
2014
Country
United States
United States
Employees
15660
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
GEF
TNGX
Price
$87.91
$23.88
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
$73.33
$21.78
AVG Volume (30 Days)
258.6K
2.0M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
3.42%
N/A
EPS Growth
N/A
26.89
EPS
N/A
N/A
Revenue
$5,448,100,000.00
$62,384,000.00
Revenue This Year
$0.94
N/A
Revenue Next Year
$1.34
N/A
P/E Ratio
$4.09
N/A
Revenue Growth
N/A
48.29
52 Week Low
$55.75
$6.25
52 Week High
$90.57
$34.39

Technical Indicators

Market Signals
Indicator
GEF
TNGX
Relative Strength Index (RSI) 64.31 35.64
Support Level $85.76 $19.74
Resistance Level $90.57 $25.76
Average True Range (ATR) 2.10 1.47
MACD -0.66 -0.33
Stochastic Oscillator 39.44 8.23

Price Performance

Historical Comparison
GEF
TNGX

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: